Literature DB >> 9324211

Detection of BK polyomavirus genotypes in healthy and HIV-positive children.

C Di Taranto1, V Pietropaolo, G B Orsi, L Jin, L Sinibaldi, A M Degener.   

Abstract

Urine samples from 211 community children (3-7 years age), from 33 HIV type-1 infected children and from 56 HIV-negative children were collected and analyzed for the presence of BK virus (BKV) DNA by PCR. PCR amplifications were carried out using primers specific for the BKV structural region VP1. We also investigated the distribution of BKV subtypes by a restriction fragment polymorphism assay (RFLP). We demonstrated BKV DNA in 3.8% of 211 community children with a higher prevalence of subtype I. In HIV-1 positive children we detected BKV DNA in 2 urine samples (6%) out of 33, both belonging to subtype I. The HIV-negative cluster did not show any positivity to BKV DNA. The results confirm a more frequent primary BKV infection in children of 3-5 years of age and a higher prevalence in hospitalized children affected by HIV-1. The most relevant finding was that among both the community and HIV-1 positive children the subtype I was the most frequently detected.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9324211     DOI: 10.1023/a:1007371320999

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  16 in total

1.  Association of polyomaviruses JC, SV40, and BK with human brain tumors.

Authors:  K Dörries; G Loeber; J Meixensberger
Journal:  Virology       Date:  1987-09       Impact factor: 3.616

Review 2.  Occurrence and significance of papovaviruses BK and JC in the urine.

Authors:  R R Arthur; K V Shah
Journal:  Prog Med Virol       Date:  1989

3.  New human papovavirus (B.K.) isolated from urine after renal transplantation.

Authors:  S D Gardner; A M Field; D V Coleman; B Hulme
Journal:  Lancet       Date:  1971-06-19       Impact factor: 79.321

4.  Progressive multifocal leucoencephalopathy: detection of papovavirus JC in kidney tissue.

Authors:  K Dörries; V ter Meulen
Journal:  J Med Virol       Date:  1983       Impact factor: 2.327

5.  Age-dependent prevalence of BK virus IgG and IgM antibodies measured by enzyme-linked immunosorbent assays (ELISA).

Authors:  T Flaegstad; T Traavik; B E Kristiansen
Journal:  J Hyg (Lond)       Date:  1986-06

6.  Prevalence and distribution of BK virus subtypes in healthy people and immunocompromised patients detected by PCR-restriction enzyme analysis.

Authors:  L Jin; V Pietropaolo; J C Booth; K H Ward; D W Brown
Journal:  Clin Diagn Virol       Date:  1995-03

7.  The role of BK virus in acute respiratory tract disease and the presence of BKV DNA in tonsils.

Authors:  J Goudsmit; P Wertheim-van Dillen; A van Strien; J van der Noordaa
Journal:  J Med Virol       Date:  1982       Impact factor: 2.327

8.  Rapid genomic typing of BK virus directly from clinical specimens.

Authors:  L Jin
Journal:  Mol Cell Probes       Date:  1993-08       Impact factor: 2.365

9.  Genomic typing of BK virus in clinical specimens by direct sequencing of polymerase chain reaction products.

Authors:  L Jin; P E Gibson; J C Booth; J P Clewley
Journal:  J Med Virol       Date:  1993-09       Impact factor: 2.327

10.  BK and JC viruses in human immunodeficiency virus type 1-infected persons: prevalence, excretion, viremia, and viral regulatory regions.

Authors:  A Sundsfjord; T Flaegstad; R Flø; A R Spein; M Pedersen; H Permin; J Julsrud; T Traavik
Journal:  J Infect Dis       Date:  1994-03       Impact factor: 5.226

View more
  15 in total

1.  Phylogenetic analysis of polyomavirus BK sequences.

Authors:  Preety M Sharma; Gaurav Gupta; Abhay Vats; Ron Shapiro; Parmjeet Randhawa
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

2.  A Simple and Reliable Strategy for BK Virus Subtyping and Subgrouping.

Authors:  Virginie Morel; Elodie Martin; Catherine François; François Helle; Justine Faucher; Thomas Mourez; Gabriel Choukroun; Gilles Duverlie; Sandrine Castelain; Etienne Brochot
Journal:  J Clin Microbiol       Date:  2017-02-01       Impact factor: 5.948

3.  Evolution of BK virus based on complete genome data.

Authors:  Yuriko Nishimoto; Tomokazu Takasaka; Masami Hasegawa; Huai-Ying Zheng; Qin Chen; Chie Sugimoto; Tadaichi Kitamura; Yoshiaki Yogo
Journal:  J Mol Evol       Date:  2006-07-28       Impact factor: 2.395

4.  VP-1 quasispecies in human infection with polyomavirus BK.

Authors:  Chunqing Luo; Hans H Hirsch; Jeffrey Kant; Parmjeet Randhawa
Journal:  J Med Virol       Date:  2011-11-03       Impact factor: 2.327

5.  BK virus infection in human immunodeficiency virus-infected patients.

Authors:  J Ledesma; P Muñoz; D Garcia de Viedma; I Cabrero; B Loeches; P Montilla; P Gijon; B Rodriguez-Sanchez; E Bouza
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-11-16       Impact factor: 3.267

6.  Transcriptional regulation of BK virus by nuclear factor of activated T cells.

Authors:  Joslynn A Jordan; Kate Manley; Aisling S Dugan; Bethany A O'Hara; Walter J Atwood
Journal:  J Virol       Date:  2009-12-02       Impact factor: 5.103

7.  Mutations in the external loops of BK virus VP1 and urine viral load in renal transplant recipients.

Authors:  Sara Tremolada; Serena Delbue; Lorenzo Castagnoli; Sara Allegrini; Umberto Miglio; Renzo Boldorini; Francesca Elia; Jennifer Gordon; Pasquale Ferrante
Journal:  J Cell Physiol       Date:  2010-01       Impact factor: 6.384

8.  Infection of vero cells by BK virus is dependent on caveolae.

Authors:  Sylvia Eash; William Querbes; Walter J Atwood
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

9.  An Asian origin for subtype IV BK virus based on phylogenetic analysis.

Authors:  Yuriko Nishimoto; Huai-Ying Zheng; Shan Zhong; Hiroshi Ikegaya; Qin Chen; Chie Sugimoto; Tadaichi Kitamura; Yoshiaki Yogo
Journal:  J Mol Evol       Date:  2007-06-25       Impact factor: 2.395

10.  Biologic diversity of polyomavirus BK genomic sequences: Implications for molecular diagnostic laboratories.

Authors:  C Luo; M Bueno; J Kant; P Randhawa
Journal:  J Med Virol       Date:  2008-10       Impact factor: 2.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.